Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 2/20 | 0.71 |
| ▸ | ADRB2 | P07550 | 18/20 | 0.63 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.63 |
| ▸ | DRD2 | P14416 | 1/20 | 0.63 |
| ▸ | PDE4A | P27815 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30438565 | 1.00 | ABCB11 (0.71) | ABCB11ADRB2ADRB1DRD2PDE4A | |
| Hydrochloric Acid SCHEMBL5051545 | 0.99 | ABCB11 (0.70) | ABCB11ADRB2ADRB1DRD2PDE4A | |
| SCHEMBL8088585 | 0.92 | ABCB11 (0.71) | ABCB11ADRB2ADRB1DRD2PDE4A | |
| SCHEMBL8104306 | 0.92 | ABCB11 (0.71) | ABCB11ADRB2ADRB1DRD2PDE4A | |
| SCHEMBL8095472 | 0.92 | ABCB11 (0.84) | ABCB11ADRB2ADRB1DRD2PDE4A | |
| Hydrochloric Acid SCHEMBL8097788 | 0.91 | ABCB11 (0.70) | ABCB11ADRB2ADRB1DRD2PDE4A | |
| Hydrochloric Acid SCHEMBL8098171 | 0.91 | ABCB11 (0.70) | ABCB11ADRB2ADRB1DRD2PDE4A | |
| Hydrochloric Acid SCHEMBL8088900 | 0.91 | ABCB11 (0.82) | ABCB11ADRB2ADRB1DRD2PDE4A | |
| SCHEMBL8095311 | 0.88 | ABCB11 (0.62) | ABCB11ADRB2ADRB1DRD2PDE4A | |
| SCHEMBL8088395 | 0.88 | ABCB11 (0.67) | ABCB11ADRB2ADRB1DRD2PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2448623-B1 | DISPENSER AND METHOD FOR ENTRAINING POWDER IN AN AIRFLOW | ASTRAZENECA AB (SE) | 2017-12-20 | — | — | EP | claimed |
| EP-2341968-B1 | A BREATH ACTIVATED INHALER | ASTRAZENECA AB (SE) | 2017-05-10 | — | — | EP | claimed |
| US-9289565-B2 | Inhaler with indexing linked to movement of cover | ASTRAZENECA AB (SE) | 2016-03-22 | — | — | US | claimed |
| EP-2334358-B1 | INHALATION DEVICE FOR DISPENSING MEDICAMENT | ASTRAZENECA AB (SE) | 2016-02-10 | — | — | EP | claimed |
| US-9155851-B2 | Breath activated inhaler | ASTRAZENECA AB (SE) | 2015-10-13 | — | — | US | claimed |
| US-9095670-B2 | Inhalation device and method of dispensing medicament | ASTRAZENECA AB (SE) | 2015-08-04 | — | — | US | claimed |
| EP-2595683-B1 | Inhaler | ASTRAZENECA AB (SE) | 2015-03-04 | — | — | EP | claimed |
| US-20140083422-A1 | INHALER | ASTRAZENECA AB | 2014-03-27 | — | — | US | claimed |
| US-8578933-B2 | Entraining powder in an airflow | ASTRAZENECA AB (SE) | 2013-11-12 | — | — | US | claimed |
| EP-2595683-A2 | INHALER | AstraZeneca AB (SE) | 2013-05-29 | — | — | EP | claimed |
| US-20050106335-A1 | Novel process for coating inhalation devices | ASTRAZENECA AB (SE) | 2005-05-19 | — | — | US | claimed |
| EP-1345591-B1 | PHARMACEUTICAL AEROSOL FORMULATION | ASTRAZENECA AB (SE) | 2005-03-02 | — | — | EP | claimed |
| EP-1474197-A1 | NOVEL PROCESS FOR COATING INHALATION DEVICES | AstraZeneca AB (SE) | 2004-11-10 | — | — | EP | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1345591-A1 | PHARMACEUTICAL AEROSOL FORMULATION | AstraZeneca AB (SE) | 2003-09-24 | — | — | EP | claimed |
| WO-2003063938-A1 | NOVEL PROCESS FOR COATING INHALATION DEVICES | ASTRAZENECA AB (SE) | 2003-08-07 | — | — | WO | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002049616-A1 | PHARMACEUTICAL AEROSOL FORMULATION | ASTRAZENECA AB (SE) | 2002-06-27 | — | — | WO | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| EP-0850232-B1 | BENZOTHIAZOLONE DERIVATIVES | ASTRA PHARMA PROD (GB) | 2000-03-15 | — | — | EP | claimed |